The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News:
----------
Ebiquity PLC - London-based media and marketing consultancy - For the six months ended June 30, reports pretax loss of £900,000, swung from £1.4 million profit a year prior. Revenue also declines, falling 7% to £37.9 million from £40.6 million. Staff costs rise to £26.0 million from £25.1 million. The firm says trading conditions continued to be poor from the fourth quarter of 2023, and that its cost base is largely exacerbating the profit impact of revenue shortfalls. Looking ahead, Ebiquity expects the combination of the group’s new business wins, renewals and upselling opportunities to outweigh continuing market headwinds in the second half, leading to a mid-single-digit revenue growth for the second half versus a year prior.
----------
Angle PLC - Guildford, England-based liquid biopsy company - For the six months ended June 30, posts pretax loss of £8.3 million, narrowed from £10.6 million the previous year. Revenue falls to £1.0 million from £1.2 million, with a sold order book of up to £1.9 million at period end. Operating costs fall to £8.9 million from £11.4 million. In the near future, Angle sees ‘encouraging momentum’, with a growing pipeline of large pharma and corporate opportunities to build future large-scale revenue opportunities. Additionally, says all three large pharma agreements with Eisai Co Ltd and AstraZeneca PLC are progressing well and, if successful, have the potential to lead to substantially larger contracts for deployment in clinical trials.
----------
Keras Resources PLC - Surrey, England-based mine developer focused on West Africa and the US - For the six months to June 30, posts pretax loss of £436,000, widened from £255,000 a year prior. Attributes this to increased non-capital items related to the move to the Delta Facility and the exclusion of the extra-ordinary items in the comparable period in 2023. Revenue increases to £556,000 from £397,000, while basic and diluted loss per share widens to 0.54 pence from 0.28p. Chief Executive Officer Graham Stacey says: ‘For the rest of the year, operationally our focus will shift from infrastructure development to commercial production growth and from a product development perspective we will now focus on liquid organic product(s) with higher phosphate availability, building on our research carried out in 2023.’
----------
Malvern International PLC - London-based learning and skills development company, which provides university pathway programmes, English language training, and teaching courses - For the six months ended June 30, reports pretax profit of £139,000, down from £222,000 a year prior. Revenue rises to £6.1 million from £4.9 million, while earnings per share fall to 0.57p from 0.91p the previous year. Looking ahead, says forward bookings and increased revenue visibility give board confidence in firm’s short and long-term prospects. CEO Richard Mace adds: ‘Our performance in H1 2024 reflects the investment made across the business over the past three years. This investment is ongoing, and we are currently in a transition phase where top-line revenue growth is fuelling further investment in our sales and marketing, teaching, and back-office functions, setting the stage for accelerated growth in 2025. Whilst Pathways and Juniors are thriving due to strong demand, our adult ELT centres are not experiencing equal growth. We are taking measures to address this, including launching low-season and academic group programmes to improve staff and centre utilisation throughout the year at our permanent schools.’
----------
Copyright 2024 Alliance News Ltd. All Rights Reserved.
